Techcomp Holdings Ltd reports 6.5% revenue growth in FY2016
16/03/2017 • About Techcomp Holdings Ltd (
$1298) • By InTwits
Techcomp Holdings Ltd reported FY2016 financial results today. Below you can find a comprehensive analysis of the key data driving the company's performance and stock price.
Techcomp Holdings Ltd ($1298) key annual financial indicators
| mln. $ | 2012 | 2013 | 2014 | 2015 | 2016 | 2016/2015 |
|---|
P&L
|
|---|
| Revenue | 157.7 | 166.4 | 162.7 | 171.9 | 183.0 | 6.5% |
| Gross Profit | 43.1 | 50.2 | 50.7 | 55.5 | | -100.0% |
| SG&A | | | | 51.6 | | -100.0% |
| EBITDA | 7.1 | 7.4 | 9.5 | 7.6 | | -100.0% |
| Net Income | 3.2 | 3.7 | 3.4 | 3.5 | 1.0 | -71.2% |
Balance Sheet
|
|---|
| Cash | 17.0 | 14.7 | 16.1 | 16.0 | | -100.0% |
| Short Term Debt | 30.3 | 31.3 | 33.3 | 25.7 | | -100.0% |
| Long Term Debt | 16.8 | 10.3 | 8.2 | 12.9 | | -100.0% |
Cash flow
|
|---|
| Capex | 0.5 | 1.3 | 2.4 | 0.9 | | -100.0% |
Ratios
|
|---|
| Revenue growth | 2.3% | 5.6% | -2.3% | 5.7% | 6.5% | |
| EBITDA growth | -45.7% | 4.9% | 28.3% | -20.6% | | |
| Gross Margin | 27.3% | 30.2% | 31.2% | 32.3% | | -32.3% |
| EBITDA Margin | 4.5% | 4.5% | 5.9% | 4.4% | 0.0% | -4.4% |
| Net Income Margin | 2.0% | 2.2% | 2.1% | 2.0% | 0.6% | -1.5% |
| SG&A, % of revenue | | | | 30.0% | | -30.0% |
| CAPEX, % of revenue | 0.3% | 0.8% | 1.5% | 0.5% | | -0.5% |
| ROIC | 3.5% | 3.5% | 4.8% | 3.9% | | -3.9% |
| ROE | 5.1% | 5.7% | 4.7% | 4.3% | | -4.3% |
| Net Debt/EBITDA | 4.3x | 3.6x | 2.7x | 3.0x | | -3.0x |
Revenue and profitability
The company's Revenue increased on 6.5%.
Net Income marign decreased slightly on 1.5 pp from 2.0% to 0.55% in FY2016.
Appendix 1: Peers in Healthcare-Products
Below you can find Techcomp Holdings Ltd benchmarking vs. other companies in Healthcare-Products industry. It's shown for the period of 5 years for the key financial metrics. Each table has median value for all the companies in the industry together with individual financial data of the top-5 companies in the industry by particular financial metric.
Top companies by Revenue growth, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Vitop Bioenergy Holdings Ltd ($1178) | | -3.2% | -27.3% | 92.4% | 281.7% |
| Beijing Chunlizhengda Medical Instruments Co Ltd ($1858) | 22.2% | 12.8% | 21.8% | 32.0% | |
| China Medical System Holdings Ltd ($867) | 30.8% | 26.5% | 31.0% | 20.7% | |
| Shandong Weigao Group Medical Polymer Co Ltd ($1066) | 16.0% | 25.1% | 14.4% | 12.1% | |
| BBI Life Sciences Corp ($1035) | 16.4% | 18.0% | 15.1% | 11.5% | |
| |
|---|
| Median (16 companies) | 16.2% | 15.4% | 13.0% | 5.2% | -18.4% |
|---|
| Techcomp Holdings Ltd ($1298) | | 5.6% | -2.3% | 5.7% | 6.5% |
Top companies by Gross margin, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Lifetech Scientific Corp ($1302) | 80.1% | 81.6% | 81.4% | 81.1% | |
| PW Medtech Group Ltd ($1358) | 66.0% | 67.9% | 72.8% | 75.1% | |
| Golden Meditech Holdings Ltd ($801) | 69.1% | 69.8% | 70.2% | 72.8% | 45.8% |
| Beijing Chunlizhengda Medical Instruments Co Ltd ($1858) | 71.6% | 72.1% | 73.8% | 68.6% | |
| Microport Scientific Corp ($853) | 83.6% | 81.0% | 68.5% | 67.2% | |
| |
|---|
| Median (16 companies) | 55.2% | 52.9% | 50.6% | 50.7% | 21.7% |
|---|
| Techcomp Holdings Ltd ($1298) | 27.3% | 30.2% | 31.2% | 32.3% | |
Top companies by EBITDA margin, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| PW Medtech Group Ltd ($1358) | 44.2% | 30.6% | 41.6% | 48.6% | |
| Lifetech Scientific Corp ($1302) | 31.6% | 24.5% | 23.4% | 33.1% | |
| China Medical System Holdings Ltd ($867) | 34.5% | 32.4% | 39.4% | 32.3% | |
| Hengan International Group Co Ltd ($1044) | 27.4% | 25.3% | 25.3% | 28.0% | |
| Shandong Weigao Group Medical Polymer Co Ltd ($1066) | 28.5% | 28.0% | 29.0% | 27.8% | |
| |
|---|
| Median (16 companies) | 26.6% | 24.9% | 13.6% | 11.1% | -38.3% |
|---|
| Techcomp Holdings Ltd ($1298) | 4.5% | 4.5% | 5.9% | 4.4% | |
Top companies by CAPEX/Revenue, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Lifetech Scientific Corp ($1302) | 0.0% | 16.5% | 0.0% | 70.0% | |
| PW Medtech Group Ltd ($1358) | 14.8% | 22.3% | 30.2% | 42.1% | |
| Arts Optical International Hldgs ($1120) | 14.0% | 4.5% | 14.0% | 29.9% | |
| Golden Meditech Holdings Ltd ($801) | 12.7% | 51.2% | 27.3% | 26.1% | 56.4% |
| BBI Life Sciences Corp ($1035) | 23.6% | 6.7% | 6.4% | 20.0% | |
| |
|---|
| Median (16 companies) | 9.6% | 6.6% | 6.7% | 7.4% | 1.7% |
|---|
| Techcomp Holdings Ltd ($1298) | 0.3% | 0.8% | 1.5% | 0.5% | |
Top companies by ROIC, %
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Lifetech Scientific Corp ($1302) | 17.5% | 15.9% | 21.2% | 32.9% | |
| China Medical System Holdings Ltd ($867) | 19.4% | 20.2% | 27.4% | 20.5% | |
| Hengan International Group Co Ltd ($1044) | 19.5% | 14.9% | 14.0% | 16.4% | |
| Beijing Chunlizhengda Medical Instruments Co Ltd ($1858) | 22.2% | 20.9% | 21.0% | 12.1% | |
| Shandong Weigao Group Medical Polymer Co Ltd ($1066) | 10.5% | 11.7% | 12.8% | 11.8% | |
| |
|---|
| Median (16 companies) | 10.3% | 8.4% | 5.3% | 4.7% | -4.1% |
|---|
| Techcomp Holdings Ltd ($1298) | 3.5% | 3.5% | 4.8% | 3.9% | |
Top companies by Net Debt / EBITDA
| Top 5 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|
| Microport Scientific Corp ($853) | -1.0x | -2.8x | | 4.3x | |
| Hengan International Group Co Ltd ($1044) | 1.4x | 1.7x | 1.8x | 1.7x | |
| China Medical System Holdings Ltd ($867) | -0.4x | -0.2x | 0.2x | -0.0x | |
| PW Medtech Group Ltd ($1358) | -1.2x | -7.5x | -0.3x | -1.1x | |
| Lifetech Scientific Corp ($1302) | -3.5x | -2.8x | -2.7x | -1.1x | |
| |
|---|
| Median (11 companies) | -1.2x | -1.6x | -1.5x | -1.6x | 0.9x |
|---|
| Techcomp Holdings Ltd ($1298) | 4.3x | 3.6x | 2.7x | 3.0x | |
